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Nanoliposomes are among technological delivery developments for chemotherapeutic drugs in the 
treatment of cancer. This technique can potentially overcome many common pharmacologic problems, 
such as those involving solubility, pharmacokinetics, in vivo stability and toxicity.[1,2] In this work, the 
fluorescence properties of new potential antitumoral 1,3-diarylureas in the thieno[3,2-b]pyridine series, 
1a-c, were studied in solution and in lipid membranes of different composition and charge, either 
cationic, neutral (zwitterionic) or anionic. Nanosized liposomes were prepared using egg yolk 
phosphatidylcholine (Egg-PC) dioctadecyldimethylammonium bromide (DODAB), dipalmitoyl 
phosphatidylcholine (DPPC) and dipalmitoyl phosphatidylglycerol (DPPG), with or without cholesterol 
(Ch). Compounds 1a-c present very reasonable fluorescence quantum yields in different solvents (0.10 ≤ 
ΦF ≤ 0.30) and exhibit a red shift in emission with increasing solvent polarity. However, they are not 
fluorescent in protic solvents (like alcohols and water). 
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   Figure 1. Normalised fluorescence spectra of compound 1a  
in lipid membranes of DPPC, Egg-PC and DPPC/Ch 7:3. 
 
All compounds exhibit reasonable fluorescence emission when incorporated in lipid membranes (Figure 
1), indicating that they can be transported in the hydrophobic region of the lipid bilayer. Fluorescence 
anisotropy measurements of the compounds incorporated in nanoliposomes show notable anisotropy 
variations when fluidity increases above the melting transition temperature or by addition of cholesterol. 
These results may be important for future drug delivery applications of these potential antitumoral 
compounds using nanoliposomes as drug carriers. 
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